Igm Biosciences Inc (IGMS) Return on Investment ROI from the second quarter of 2025 to second quarter of 2024 and for the year 2025, average high and low, overall ranking from Jun 30 2025 to Jun 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Igm Biosciences Inc   (NASDAQ: IGMS)


Igm Biosciences Inc's ROI from its second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Igm Biosciences Inc's ROI in the second quarter of 2025?
Igm Biosciences Inc recorded a cumulative net loss of $-53 million during 12 months ending in the second quarter of 2025, resulting in a negative return on investment (ROI) of -27.8%.

Within the Healthcare sector 391 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2025 from 3079 to 3593.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Investment Change TTM -46.99 % -39.12 % -32.51 % -27.18 % -20.4 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 101 179 228 261 299
Return On Investment (TTM) -27.8 % -82.34 % -69.57 % -68.78 % -60.83 %
IGMS's Overall Ranking # 3593 # 3079 # 2440 # 3787 # 3728
Seq. Investment Change TTM -20.48 % -14.17 % -11.96 % -11.79 % -8.67 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -53 -199 -196 -220 -220

IGMS Company Profile >> Back to IGMS Roi Comparisons >> See Annual IGMS Return On Investment



Return On Investment IGMS's Ranking
Within: No.
Industry # 148
Sector # 392
Overall # 3593

Return On Investment Statistics
High Average Low
-12.68 %
-45.11 %
-82.34 %
(Dec 31 2019)   (Mar 31 2025)







Financial Statements
Igm Biosciences Inc's II. Quarter Investments $ 101 Millions IGMS's Balance sheet
Igm Biosciences Inc's II. Quarter Income $ 98 Millions Quarterly IGMS's Income Statement
IGMS's Income by Division See IGMS's Income by Division


IGMS Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 228 381 469 270 391
Y / Y Investment Growth -40.13 % -18.75 % 73.41 % -30.93 % 55.02 %
Net Income in Millions -196 -246 -221 -165 -81
Y / Y Net Income Growth - - - - -
Annual Return On Investment -85.85 % -64.69 % -47.16 % -61.09 % -20.79 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IGMS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IGMS's Competitors
Subscribers only: Roi for Igm Biosciences Inc's Suppliers
Subscribers only: Return On Investment for IGMS's Customers

Other Ratios
IGMS's Roa IGMS's Inventory Turnover Ratio IGMS's Growth Rates IGMS's Dividend Statistics
IGMS's Profitability Ratios IGMS's Asset Turnover Ratio IGMS's Dividend Growth
IGMS's Roe IGMS's Valuation Ratios IGMS's Financial Strength Ratios IGMS's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2025, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.